["Le Guide des prix des ARV pour les PED" (ex Démêler l'écheveau des prix...!) publié depuis 2001 par Msf vient d'être actualisé (8ème édition). CB]
Untangling the web of price reductions: a pricing guide for the purchase of
ARVs for developing countries
8th Edition, juin 2005, Campagne d'accès aux médicaments essentiels, Msf
http://www.accessmed-msf.org/documents/untanglingtheweb%208.pdf
"MSF has found that problems fall into three categories:
1) some singlesource drugs are very expensive,
2) differential prices are not really available as advertised in developing
countries because some companies do not register their products in poor
countries,
3) some companies do not offer discounted prices in middleincome countries."
3 Table of contents
4 General background and objectives
5 Methodology
6 Analysis of current offers limitations: are products getting to patients
in need?
8 Graph 1: Comparison between prices published in this report and prices
reported by Global Fund
9 Graph 2: Prices of medicines recommended as 1st and 2nd line by WHO,
January 2005
10 Graph 3: The Effects of Generic Competition
12 Table 1: 1st and 2nd category of prices offered by manufacturers for the
different countries (yearly and unit price)
15 Table 2: Summary table for conditions
17 Annexes
17 Annex 1: Least Developed Countries (LDCs)
17 Annex 2: Human Development Index (HDI)
17 Annex 3: Sub-Saharan countries
18 Annex 4: World Bank low-income and low-middle-income countries
18 Annex 5: Company contacts
20 Glossary
Table of contents
M.decins Sans Frontires ¥ www.accessmed-msf.org ¥ June 2005 ¥ Untangling
the Web of Price Reductions ¥ 3
Carinne Bruneton
Déléguée générale
Réseau Médicaments et Développement (ReMeD)
35 rue Daviel, 75 013 Paris
tél 33 1 53 80 20 20, fax 33 1 53 80 20 21
remed@remed.org ou remed.75013@wandoo.fr
web : http://www.remed.org